638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results

BACKGROUND: Long-acting (LA) injectable suspensions of cabotegravir (CAB) & rilpivirine (RPV) are in phase III development. LATTE-2 W160 results demonstrated high rates of virologic response & overall tolerability. This W256 analysis evaluated long-term efficacy, safety, & tolerability o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Smith, Graham, Henry, Keith, Podzamczer, Daniel, Masiá, Mar, Bettacchi, Christopher, Arasteh, Keikawus, Jaeger, Hans, Khuong-Josses, Marie-Aude, Sutton, Kenneth, Zhang, Feifan, McCoig, Cynthia C, Vandermeulen, Kati, Van Solingen-Ristea, Rodica, Spreen, William, Margolis, David
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778165/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.832
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados